Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.
- Gonçalo Andrade, PhD, Business Development Manager
- Peter Villax, Vice President of Innovation
- Carla Vozone, Senior Director, Product Development and Licensing